Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1
- PMID: 15743889
- DOI: 10.1152/ajpcell.00461.2004
Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1
Abstract
In Alzheimer's disease (AD), one finds increased presence of monocytes/macrophages and activated microglial cells in the brain. Immunohistochemical studies show increased expression of chemokine receptor 5 (CCR5) on reactive microglia associated with amyloid deposits in AD, suggesting that CCR5 may play a role in the regulation of the immune response in AD. In this study, we used peripheral blood monocytes and human monocytic THP-1 cell line as a model of microglia to delineate the cellular signaling mechanism of Abeta-induced CCR5 expression and the latter's role in the chemotaxis of monocytes. We observed that Abeta peptides at pathophysiological concentrations (125 nM) increased CCR5 mRNA and cell surface protein expression. The cellular signaling involved activation of c-Raf, ERK-1/ERK-2, and c-Jun NH(2)-terminal kinase. Analysis of some transcription factors associated with CCR5 promoter revealed that Abeta increased DNA binding activity of Egr-1 and AP-1. In addition, we show that CCR5 promoter contains an Egr-1 like consensus sequence GCGGGGGTG as demonstrated by 1) electrophoretic mobility shift assay, 2) transfection studies with truncated CCR5 gene promoter construct, and 3) chromatin immunoprecipitation analysis. Moreover, transfection of Egr-1 siRNA, but not of scrambled Egr-1 siRNA, in THP-1 cells resulted in >75% reduction in both Abeta-mediated CCR5 expression and concomitant chemotaxis to its ligands. We suggest that inhibition of Egr-1 by either Egr-1 siRNA or pharmacological agents may reduce activation of monocytes/microglia and possibly ameliorate the inflammation and progression of AD.
Similar articles
-
Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor.J Neurochem. 2004 Dec;91(5):1199-210. doi: 10.1111/j.1471-4159.2004.02800.x. J Neurochem. 2004. PMID: 15569263
-
Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA.J Immunol. 2003 May 15;170(10):5281-94. doi: 10.4049/jimmunol.170.10.5281. J Immunol. 2003. PMID: 12734378
-
Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.J Immunol. 2009 May 1;182(9):5778-88. doi: 10.4049/jimmunol.0803013. J Immunol. 2009. PMID: 19380826
-
Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease.Int J Mol Sci. 2020 Feb 21;21(4):1472. doi: 10.3390/ijms21041472. Int J Mol Sci. 2020. PMID: 32098198 Free PMC article. Review.
-
Entanglement of CCR5 and Alzheimer's Disease.Front Aging Neurosci. 2019 Aug 7;11:209. doi: 10.3389/fnagi.2019.00209. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31447666 Free PMC article. Review.
Cited by
-
Monocytic C-C chemokine receptor 5 expression increases in in vitro intermittent hypoxia condition and in severe obstructive sleep apnea patients.Sleep Breath. 2019 Dec;23(4):1177-1186. doi: 10.1007/s11325-019-01797-4. Epub 2019 Feb 18. Sleep Breath. 2019. PMID: 30778913 Free PMC article.
-
Induction of early growth response-1 mediates microglia activation in vitro but is dispensable in vivo.Neuromolecular Med. 2009;11(2):87-96. doi: 10.1007/s12017-009-8061-6. Epub 2009 Apr 14. Neuromolecular Med. 2009. PMID: 19365618
-
The intricate role of CCL5/CCR5 axis in Alzheimer disease.J Neuropathol Exp Neurol. 2023 Oct 20;82(11):894-900. doi: 10.1093/jnen/nlad071. J Neuropathol Exp Neurol. 2023. PMID: 37769321 Free PMC article. Review.
-
PknE, a serine/threonine protein kinase of Mycobacterium tuberculosis initiates survival crosstalk that also impacts HIV coinfection.PLoS One. 2014 Jan 8;9(1):e83541. doi: 10.1371/journal.pone.0083541. eCollection 2014. PLoS One. 2014. Retraction in: PLoS One. 2019 Jan 17;14(1):e0211247. doi: 10.1371/journal.pone.0211247. PMID: 24421891 Free PMC article. Retracted.
-
Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer's models.Cell Rep. 2022 Sep 27;40(13):111417. doi: 10.1016/j.celrep.2022.111417. Cell Rep. 2022. PMID: 36170815 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
